Investigation of the effects of supplementation with curcuminoids in subjects with metabolic syndrome
Phase 2
- Conditions
- Metabolic syndrome
- Registration Number
- JPRN-UMIN000018339
- Lead Sponsor
- Clinical Trial Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
- Brief Summary
Significant reductions in palsma concentrations of total cholesterol, LDL-cholesterol, triglycerides,non-HDL-choletserol and lipoprotein(a), and elevations in HDL-cholesterol following 8-week supplementation with curcuminoids.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy and breastfeeding, non-compliance with the study medication (defined as not using the medication for > 1 week), participation in a concomitant trial, hypersensitivity to the study medication, presence of malignancies and Impossibility to give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method